HomeHeadlinesDr Reddy's Laboratories (DRREDDY IS) says Novo Nordisk's (NOVOB DC) Wegovy copycat will be priced competitively with 50-60% discounts feasible, according to reportsFEBRUARY 17, 2026 AT 03:47 PMDr Reddy's Laboratories (DRREDDY IS) says Novo Nordisk's (NOVOB DC) Wegovy copycat will be priced competitively with 50-60% discounts feasible, according to reportsByNewsquawk StaffImportanceLevel 1#EU SESSION#US SESSION#GLOBAL EQUITIES
FEBRUARY 17, 2026 AT 03:47 PMDr Reddy's Laboratories (DRREDDY IS) says Novo Nordisk's (NOVOB DC) Wegovy copycat will be priced competitively with 50-60% discounts feasible, according to reportsByNewsquawk StaffImportanceLevel 1#EU SESSION#US SESSION#GLOBAL EQUITIES